Two ministerial decrees published in Morocco's Official Bulletin No. 7503 on April 27, 2026, establish new application and delivery forms for the health visa required for importing human-use medicines. The stated goal is to clarify regulations and secure import channels.
The new procedures aim to reduce administrative delays while enhancing oversight of pharmaceutical imports. According to the decrees, importers must submit detailed documentation, including product specifications and manufacturing certificates, via updated forms.
Health authorities will conduct reinforced controls to ensure compliance with quality and safety standards. The measures respond to concerns about counterfeit or substandard medicines entering the market.
Industry stakeholders have welcomed the clarification but await implementation details. The decrees take effect 30 days after publication.
